Santorsola, M.; Capuozzo, M.; Nasti, G.; Sabbatino, F.; Di Mauro, A.; Di Mauro, G.; Vanni, G.; Maiolino, P.; Correra, M.; Granata, V.;
et al. Exploring the Spectrum of VEGF Inhibitors’ Toxicities from Systemic to Intra-Vitreal Usage in Medical Practice. Cancers 2024, 16, 350.
https://doi.org/10.3390/cancers16020350
AMA Style
Santorsola M, Capuozzo M, Nasti G, Sabbatino F, Di Mauro A, Di Mauro G, Vanni G, Maiolino P, Correra M, Granata V,
et al. Exploring the Spectrum of VEGF Inhibitors’ Toxicities from Systemic to Intra-Vitreal Usage in Medical Practice. Cancers. 2024; 16(2):350.
https://doi.org/10.3390/cancers16020350
Chicago/Turabian Style
Santorsola, Mariachiara, Maurizio Capuozzo, Guglielmo Nasti, Francesco Sabbatino, Annabella Di Mauro, Giordana Di Mauro, Gianluca Vanni, Piera Maiolino, Marco Correra, Vincenza Granata,
and et al. 2024. "Exploring the Spectrum of VEGF Inhibitors’ Toxicities from Systemic to Intra-Vitreal Usage in Medical Practice" Cancers 16, no. 2: 350.
https://doi.org/10.3390/cancers16020350
APA Style
Santorsola, M., Capuozzo, M., Nasti, G., Sabbatino, F., Di Mauro, A., Di Mauro, G., Vanni, G., Maiolino, P., Correra, M., Granata, V., Gualillo, O., Berretta, M., & Ottaiano, A.
(2024). Exploring the Spectrum of VEGF Inhibitors’ Toxicities from Systemic to Intra-Vitreal Usage in Medical Practice. Cancers, 16(2), 350.
https://doi.org/10.3390/cancers16020350
